Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
adoption
biotech
blockchain
boehringer ingelheim
clinical trials
eli lilly
empagliflozin
europe
europe blog main
europe top stories
fda
germany
health
indiana blog main
indiana top stories
life sciences
medicine
national blog main
new york blog main
new york top stories
slgt2 inhibitor
type 1 diabetes
type 2 diabetes
usa
What
boehringer
2
×
diabetes
patients
approval
based
bid
blockchain
create
develops
dlt
drug
eli
expand
fallen
fda
firm
giant
global
ingelheim
lilly
major
marketed
medicine’s
network
pharma
pharmaceutical
plans
powered
rejects
short
type
Language
unset
Current search:
boehringer
×
@xconomy.com
4 years ago
FDA Rejects Boehringer Ingelheim, Eli Lilly Drug for Type 1 Diabetes
@cointelegraph.com
4 years ago
Global Pharma Giant Develops DLT-Based Care Network for Diabetes Patients